Work

A phase I study of oral belinostat (PXD101) in patients with advanced solid tumors.

Year: 2007

Type: article

Study design: Clinical Trial

Source: Molecular Cancer Therapeutics

Authors: R. Molife, James Lee, Daniel Petrylak, George R. Blumenschein, Ulrik Lassen, Jayme Clark, Timothy A. Yap, Elin Rowen, J.E. Ang, Elizabeth Crowley, Anne Clarke, Thomas Hawthorne, P. Buhl-Jensen, Johann S. de Bono, Wm. Kevin Kelly

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2564351495

FWCI:

Cites:

Cited by: 3

Related to: 10